| Literature DB >> 28822194 |
Qi Qi1, Pei Zhang2, Qi-Xiang Li2, Qiong Pan2, Hai-Lun Zheng3, Su-Rong Zhao2.
Abstract
Oridonin, which is an ent-kaurene diterpenoid isolated from traditional Chinese medicine Rabdosia rubescens, displays various bioactivities, including anti-inflammation, anti-bacteria and anti-tumor. This study aimed to investigate the effect of oridonin on apoptosis of triple-negative breast cancer MDA-MB-231 cells and its underlying mechanisms. The inhibitory effect of oridonin on proliferation of MDA-MB-231 cells was measured by MTT assay; Apoptosis was analyzed by flow cytometry with PI staining and Annexin V-FITC/PI staining; Intracellular reactive oxygen species (ROS) level was determined by ROS detection kit, and expressions of PARP, Bcl-2, caspase-3 were analyzed by Western blot. The results showed that oridonin exhibited a significant effect in inducing apoptosis of MDA-MB-231 cells, enhancing intracellular ROS level, down-regulating expression of Bcl-2 protein, and promoting cleavage of caspase-3 and its substrate PARP. These results indicated that the apoptosis-inducing effect of oridonin on MDA-MB-231 cells might be correlated with increase of intracellular ROS level, down-regulation of Bcl-2 protein and activation of caspase-3. Copyright© by the Chinese Pharmaceutical Association.Entities:
Keywords: apoptosis ; breast cancer ; oridonin ; reactive oxygen
Mesh:
Substances:
Year: 2017 PMID: 28822194 DOI: 10.19540/j.cnki.cjcmm.2017.0114
Source DB: PubMed Journal: Zhongguo Zhong Yao Za Zhi ISSN: 1001-5302